These data provide evidence that ssON treatment is able to dampen the upregulation of Tpsab1, Mmp9, and Cma1 in murine skin induced by LL-37 and subsequently reduces the LL-37-mediated inflammation in a murine model of rosacea. Here, MMP9 is linked to rosacea.